Literature DB >> 18358739

Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages.

Lauren Kent1, Lucy Smyth2, Chris Clayton3, Laurie Scott4, Ted Cook5, Richard Stephens6, Steve Fox7, Peter Hext8, Stuart Farrow9, Dave Singh10.   

Abstract

Macrophages are key inflammatory cells in chronic obstructive pulmonary disease (COPD). The transcriptional regulation of inflammatory signalling pathways by cigarette smoke (CS) in COPD macrophages is not well understood. We have studied the effects of acute CS exposure on COPD macrophage cytokine, chemokine and signal transduction gene expression profiles. Monocyte derived macrophages (MDMs) from whole blood from patients with COPD (n=6) were stimulated with 1%, 10% and 25% CS extract (CSE) for 6h for microarray and quantitative polymerase chain reaction (Q-PCR) analysis. We observed a CSE dose dependant increase in the numbers of significantly regulated genes; 24, 340 and 627 genes at 1%, 10% and 25% CSE, respectively. IL-8 mRNA levels were up-regulated by 10% CSE (2.25-fold increase, 95% CI 1.28-4.00). In contrast a range of other cytokines and chemokines were down-regulated at both 10% and 25% CSE, including IL-1beta, -6, -10 and -18, chemokine ligands CCL-2, -3, -4, -5, -8, -15, -20 and CXCL-1, -2 and -10. Q-PCR and microarray data were highly correlated (r=0.95, p=0.0001). NF-kappaB component p50 and IkappaBalpha expression were suppressed by CSE, while there was up-regulation of the AP-1 components c-Jun, FOSL1 and FOSL2. Acute CSE exposure decreased macrophage inflammatory gene expression, with the exception of increased IL-8. There was diverse regulation of key inflammatory signal pathway genes. The effects of acute CS exposure appear to encompass both up-regulation of chemotaxis mechanisms through IL-8, but also down-regulation of innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358739     DOI: 10.1016/j.cyto.2008.02.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  20 in total

1.  Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile.

Authors:  I J Uings; D Needham; J Matthews; M Haase; R Austin; D Angell; K Leavens; J Holt; K Biggadike; S N Farrow
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

2.  Cigarette smoke compounds induce cellular redox imbalance, activate NF-κB, and increase TNF-α/CRP secretion: a possible pathway in the pathogenesis of COPD.

Authors:  Tapan Dey; Prachurjya Dutta; Prasenjit Manna; Jatin Kalita; Hari Prasanna Deka Boruah; Alak Kumar Buragohain; Balagopalan Unni; Dibyajyoti Ozah; Mihir Kumar Goswami; Ratan Kumar Kotokey
Journal:  Toxicol Res (Camb)       Date:  2016-03-03       Impact factor: 3.524

3.  An agent-based model of inflammation and fibrosis following particulate exposure in the lung.

Authors:  Bryan N Brown; Ian M Price; Franklin R Toapanta; Dilhari R DeAlmeida; Clayton A Wiley; Ted M Ross; Tim D Oury; Yoram Vodovotz
Journal:  Math Biosci       Date:  2011-03-06       Impact factor: 2.144

4.  IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.

Authors:  T Southworth; A Metryka; S Lea; S Farrow; J Plumb; D Singh
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

6.  Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in mice.

Authors:  Michelle Vaz; Subbiah Rajasekaran; Haranatha R Potteti; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 7.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

Review 8.  Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations.

Authors:  Lauren A Smith; Geraldine M Paszkiewicz; Alan D Hutson; John L Pauly
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

9.  Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.

Authors:  J Armstrong; C Sargent; D Singh
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

10.  Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).

Authors:  Lauren M Kent; Lucy J C Smyth; Jonathan Plumb; Chris L Clayton; Steve M Fox; David W Ray; Stuart N Farrow; Dave Singh
Journal:  J Pharmacol Exp Ther       Date:  2008-11-12       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.